IFNG and macrophage activation syndrome: More recently, IL-18, an IFN-γ-inducing factor, is gaining attention, with higher levels reported in Still’s–MAS compared with pHLH, prompting some authors to suggest its potential to differentiate MAS from pHLH [5] or as a therapeutic target for MAS [6, 7].